Corneal astigmatism 0.5-0.75 Diopter
Showing 1 - 25 of >10,000
Myopia Trial in Columbus (Corneal Refractive Therapy-spherical, Corneal Refractive Therapy-aspherical)
Completed
- Myopia
- Corneal Refractive Therapy-spherical
- Corneal Refractive Therapy-aspherical
-
Columbus, OhioThe Ohio State University College of Optometry
Jul 27, 2022
Hemodynamic Instability, Tracheal Intubation, Dexmedetomidine Trial in Karachi (Normal saline, Dexmedetomidine 0.5 microgram/kg,
Completed
- Hemodynamic Instability
- +2 more
- Normal saline
- +2 more
-
Karachi, Sindh, PakistanSyed Muhammad Abbas
Jun 9, 2023
Keratoconus Trial (Riboflavin 5'-phosphate in 20% dextran ophthalmic solution) 0.146%)
Not yet recruiting
- Keratoconus
- Riboflavin 5'-phosphate in 20% dextran ophthalmic solution) 0.146% with UV light
- Riboflavin 5'-phosphate in 20% dextran ophthalmic solution) 0.146% without UV light
-
Boston, MassachusettsMassachusetts Eye and Ear Infirmary
Jan 12, 2023
Persistent Corneal Epithelial Defect Trial in Mexico City (KIO-201, a Crosslinked Thiolated Carboxymethyl Hyaluronic Acid 0.75%
Recruiting
- Persistent Corneal Epithelial Defect
- KIO-201, a Crosslinked Thiolated Carboxymethyl Hyaluronic Acid 0.75% (CMHA-S)
-
Mexico City, Chimalpopoca 14 Colonia Obrera, MexicoInstituto de Oftalmología Fundación Conde de Valenciana
Jul 6, 2022
Clareon IOL Retrospective Data Collection
Not yet recruiting
- Aphakia
- Astigmatism
- Clareon UVA IOL
- +2 more
-
Fort Worth, TexasAlcon Research, LLC
Mar 22, 2023
enVista Toric 0.9D Intraocular Lenses
Recruiting
- Corneal Astigmatism
- enVista Toric
- enVista non-Toric (spherical)
-
Calgary, Alberta, Canada
- +2 more
Nov 9, 2022
Cornea Ulcer Trial in Minya (Naltrexone Hydrochloride, Carboxy methyl cellulose)
Completed
- Cornea Ulcer
- Naltrexone Hydrochloride
- Carboxy methyl cellulose
-
Minya, EgyptFaculty of Medicine
Jun 20, 2023
Aphakia, Astigmatism, Presbyopia Trial in Fort Worth (Clareon Vivity IOL - Non Toric, Clareon Vivity IOL - Toric, Clareon
Not yet recruiting
- Aphakia
- +2 more
- Clareon Vivity IOL - Non Toric
- +3 more
-
Fort Worth, TexasContact Alcon Call Center for Trial Locations
Mar 22, 2023
Corneal Edema, Corneal Defect, Anterior Chamber Inflammation Trial in Los Angeles (Dextenza 0.4Mg Ophthalmic Insert,
Not yet recruiting
- Corneal Edema
- +6 more
- Dextenza 0.4Mg Ophthalmic Insert
- +3 more
-
Los Angeles, CaliforniaAdvanced Vision Care
Dec 5, 2022
Insomnia Chronic, Pain, Chronic Trial in Surrey (Clonidine pill)
Completed
- Insomnia Chronic
- Pain, Chronic
- Clonidine 0.1mg pill
- +3 more
-
Surrey, British Columbia, CanadaSalem Anaesthesia Pain Clinic
Nov 15, 2022
Anesthesia Trial in Singapore (0.5 MAC desflurane, 0.75 MAC desflurane, 1.0 MAC desflurane)
Recruiting
- Anesthesia
- 0.5 MAC desflurane
- +2 more
-
Singapore, SingaporeChangi General Hospital
Aug 2, 2021
Healthy Volunteers Trial in Melbourne (Stelara, RT-111 (0.5mg), RT-111 (0.75mg))
Not yet recruiting
- Healthy Volunteers
- Stelara
- +2 more
-
Melbourne, AustraliaNucleus Network
Jun 5, 2023
Postoperative Pain, Pregnancy, Obesity Trial in Chicago (0.9% Normal Saline, 0.2% Ropivacaine, 0.5% Ropivacaine)
Completed
- Postoperative Pain
- +2 more
- 0.9% Normal Saline
- +3 more
-
Chicago, IllinoisNorthwestern University
Dec 7, 2021
Kidney Diseases, End-Stage Kidney Disease, Hemodialysis Trial in London (Dialysate magnesium formulation of 1.5 mEq/L (0.75
Active, not recruiting
- Kidney Diseases
- +2 more
- Dialysate magnesium formulation of 1.5 mEq/L (0.75 mmol/L).
- Dialysate magnesium formulation of ≤1.0 mEq/L (≤0.5 mmol/L).
-
London, Ontario, CanadaLondon Health Sciences Centre
Oct 21, 2022
Postoperative Nausea and Vomiting, Head and Neck Surgeries Trial in Cairo (Dexmedetomidine Hydrochloride 0.5 mic/kg bolus,
Active, not recruiting
- Postoperative Nausea and Vomiting
- Head and Neck Surgeries
- Dexmedetomidine Hydrochloride 0.5 mic/kg bolus
- +2 more
-
Cairo, EgyptCairo University
Jan 4, 2023
Cystic Fibrosis, Pancreatic Insufficiency, Abnormal Glucose Tolerance Trial in Philadelphia (Dulaglutide 0.75Mg/0.5Ml Inj Pen)
Recruiting
- Cystic Fibrosis
- +3 more
- Dulaglutide 0.75Mg/0.5Ml Inj Pen
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Jan 11, 2023
ADHD, ADHD - Combined Type, Attention Deficit Hyper Activity Trial in Maitland, Miami, Las Vegas (CTx-1301 - Dexmethylphenidate
Not yet recruiting
- ADHD
- +6 more
- CTx-1301 - Dexmethylphenidate 6.25mg
- +6 more
-
Maitland, Florida
- +2 more
Jun 28, 2023
Mydriasis, Dilation Trial in United States (Phentolamine Ophthalmic Solution 0.75%, Phentolamine Ophthalmic Solution Vehicle)
Completed
- Mydriasis
- Dilation
- Phentolamine Ophthalmic Solution 0.75%
- Phentolamine Ophthalmic Solution Vehicle
-
Newport Beach, California
- +14 more
Jun 20, 2022
Dry Eye Trial in Nashville (nanomicellular cyclosporine 0.09%, Lifitegrast)
Recruiting
- Dry Eye
- nanomicellular cyclosporine 0.09%
- Lifitegrast
-
Nashville, TennesseeToyos Clinic
Oct 4, 2021
Intraocular Pressure, Corneal Opacity Trial in Murray (Loteprednol Etabonate 0.5% Oph Gel, Prednisolone Acetate 1% Oph Susp)
Completed
- Intraocular Pressure
- Corneal Opacity
- Loteprednol Etabonate 0.5% Oph Gel
- Prednisolone Acetate 1% Oph Susp
-
Murray, UtahMoran Eye Center - Midvalley Location
May 4, 2021
Dim Light Vision Disturbances Trial in United States (Phentolamine Ophthalmic Solution 0.75%, Phentolamine Ophthalmic Solution
Completed
- Dim Light Vision Disturbances
- Phentolamine Ophthalmic Solution 0.75%
- Phentolamine Ophthalmic Solution Vehicle (Placebo)
-
Newport Beach, California
- +16 more
May 20, 2022
Multiple Myeloma Trial (BCMA-TGFß CAR-T cells (0.75 x10^6 cells/kg), BCMA-TGFß CAR-T cells (1 x 10^6 cells/kg), BCMA-TGFß CAR-T
Not yet recruiting
- Multiple Myeloma
- BCMA-TGFβ CAR-T cells (0.75 x10^6 cells/kg)
- +3 more
- (no location specified)
Jul 28, 2023
Xolair® for Chronic Rhinosinusitis With Nasal Polyps
Recruiting
- Chronic Rhinosinusitis With Nasal Polyps
- Xolair
-
Bundang Gu, Gyeonggi Do, Korea, Republic ofNovartis Investigative Site
Jan 19, 2023
Myopia, Hypermetropia, Refractive Errors Trial in Philadelphia (Proparacaine Ophthalmic)
Recruiting
- Myopia
- +3 more
- Proparacaine Ophthalmic
-
Philadelphia, PennsylvaniaWills Eye Hospital
Oct 4, 2021
Multiple Sclerosis, Erectile Dysfunction, Testosterone Deficiency Trial in New Orleans (XYOSTED 75 milligram (mg) in 0.5 ML
Not yet recruiting
- Multiple Sclerosis
- +2 more
- XYOSTED 75 milligram (mg) in 0.5 ML Auto-Injector
-
New Orleans, LouisianaLSU Health Multispecilaity Clinics
Jul 19, 2022